Board meeting scheduled for May 13, 2026 to approve audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026.
Board to consider recommendation of final dividend for FY26, subject to shareholder approval at the 38th AGM.
Trading window for designated persons remains closed until 48 hours after declaration of financial results.